The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…
MIAMI — At South Beach Symposium 2017, symposium chairman Mark S. Nestor, MD, PhD, discusses the efficacy and cosmetic benefits of superficial radiation therapy to treat both non-melanoma skin cancer and recurring keloid scars. Nestor…
— Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 — Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 —…
– Record Quarterly Revenues of $4.9 million in Fourth Quarter – Full Year 2016 revenues increased 44% year-over-year to $14.8 million – Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017…
BOCA RATON, Fla., Jan. 19, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy,…
